Northern Trust
INBX icon

Northern Trust’s Inhibrx INBX Stock Holding History

Northern Trust’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.57M Buy
100,957
+7,261
+8% +$728K ﹤0.01% 2245
2026
Q1 		$6.3M Buy
93,696
+5,187
+6% +$385K ﹤0.01% 2341
2025
Q4 		$6.99M Sell
88,509
-4,148
-4% -$283K ﹤0.01% 2278
2025
Q3 		$3.12M Sell
92,657
-5,028
-5% -$124K ﹤0.01% 2774
2025
Q2 		$1.39M Sell
97,685
-18,828
-16% -$243K ﹤0.01% 3203
2025
Q1 		$1.63M Buy
116,513
+409
+0.4% +$5.55K ﹤0.01% 3027
2024
Q4 		$1.79M Buy
116,104
+3,095
+3% +$47.1K ﹤0.01% 3088
2024
Q3 		$1.77M Buy
113,009
+38,941
+53% +$547K ﹤0.01% 3076
2024
Q2 		$1.05M Buy
+74,068
New +$1.16M ﹤0.01% 3224

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's INBX Position: Q2 2026 in Review

Northern Trust increased its Inhibrx (INBX) stake by 7.7% in Q2 2026, buying an estimated $728K and bringing the position to 100,957 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Northern Trust first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Northern Trust held 100,957 shares of Inhibrx worth $9.57M as of Q2 2026.
  • Northern Trust bought 7,261 Inhibrx shares in Q2 2026, an estimated $728K.
  • Inhibrx made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2245 holding.
  • Northern Trust first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.